$10.12 -$0.30 (-2.9%)

04:30 PM EST on 01/24/20

Zynex, Inc. (NASDAQ:ZYXI)

CAPS Rating: 1 out of 5

Current Price $10.12 Mkt Cap $331.4M
Open $10.25 P/E Ratio 35.69
Prev. Close $10.12 Div. (Yield) $0.00 (0.0%)
Daily Range $10.02 - $10.45 Volume 202,964
52-Wk Range $7.78 - $11.28 Avg. Daily Vol. 325,687

Caps

How do you think NASDAQ:ZYXI will perform against the market?

Add Stock to CAPS Watchlist

All Players

10 Outperform
16 Underperform
 

All-Star Players

1 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ZYXI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

AnsgarJohn (89.45)
Submitted June 14, 2019

Zynex Sales $34m - $6,6m Cogs / $18,9 assets = 146% Gross Profitabilityso I’ll start by explaining what the gross profitability anomaly is. It is the ratio of gross profits (revenues less cost of goods sold) to total assets. Rather than relying… More

En0chRoot (< 20)
Submitted August 16, 2008

ZYNEX INCSIC: 3845 - ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSState location: CO | State of Inc.: NV | Fiscal Year End: 1231formerly: ARIZONA VENTURES INC (filings through 2003-08-19)formerly: CHINA GLOBAL DEVELOPMENT INC (filings through… More

Recent Community Commentary

Read the most recent pitches from players about ZYXI.

Recs

0
Member Avatar SmartAce (99.97) Submitted: 12/10/2019 12:37:14 PM : Underperform Start Price: $9.23 NASDAQ:ZYXI Score: -4.99

You've reached voicemail of [Jim], leave a message.
"Hi it's the library. The book 'How to Steal Library Books' is now 1 week over...UH OH"

Recs

12
Member Avatar En0chRoot (< 20) Submitted: 8/16/2008 12:10:15 AM : Underperform Start Price: $4.14 NASDAQ:ZYXI Score: +16.50

ZYNEX INC
SIC: 3845 - ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
State location: CO | State of Inc.: NV | Fiscal Year End: 1231
formerly: ARIZONA VENTURES INC (filings through 2003-08-19)
formerly: CHINA GLOBAL DEVELOPMENT INC (filings through 2003-01-15)
formerly: FOX RIVER HOLDINGS INC (filings through 2004-01-20)
formerly: IBONZAI COM INC (filings through 2001-06-12)
formerly: LIFE MEDICAL TECHNOLOGIES INC /UT/ (filings through 2000-05-25)
formerly: ZYNEX MEDICAL HOLDINGS INC (filings through 2005-08-12)
formerly: ZYNEX MEDICAL HOLDINGS INC (filings through 2008-07-08)

As best as I can tell, Zynex is taking 100-200 dollar pieces of medical equipment and renting them to rehab patients at a 95% gross margin, another way of saying they are putting a 2000% markup on the equipment. Then they are assuming that insurance companies are going to reimburse their fees, but are withholding approximately 50% of the fee under the assumption that the insurance company will not reimburse the stupid rates, only half stupid rates. So they are actually booking the sales at a 1000% markup to their cost. Nice work if you can get it, except that they appear to be collecting only enough cash to go straight into the sales force's pockets as commissions, and the rest of the revenues find their way into accounts receivable. So the extraordinary growth they are booking isn't showing us as any meaningful operating cashflow to speak of. By the way, last year the company was cited for material weakness in it's accounting, among the reasons: "Lack of timely write off of uncollectible and duplicate billings that result in an overstatement of our accounts receivable."

If I had to draw any conclusions from Zynex's financial statements, I would think it less likely that the GAAP earnings actually makes it's way into real cash flow, and more likely that that this former penny stock is inflating it's GAAP revenues and earnings, passing accounting entries from sales to accounts receivables, to a likely accounts receivable writeoff at some future date after they have gotten a few PIPEs through the door.

Either that or our nation's medical insurers have no problem paying 1000% markups on medical equipment that can be acquired just about anywhere for 1/10th the cost.

If anything positive can be said here, it's that they have managed to accrue a million dollars or so in cash from operations over the past 12 months (setting aside for a moment that this does not account for any capital expenditures which appears to eat up 100% of this amount.) I suppose someone, somewhere, might consider paying a high growth multiple, say 40x, on this cashflow, if they were able to convince themselves that the growth rates actually related to a real business earning real cash (or at least real accounts receivables with low likelihood that the current 50% loss provisions will end up being an accurate assessment of ultimate collectability, something they appear not to have the best track record on to date.) If only ZYXI wasn't trading over 5 times higher than that level...

I'm gonna go with underperform here.

Recs

0
Member Avatar Borisincincy (< 20) Submitted: 8/13/2008 12:38:26 PM : Outperform Start Price: $3.33 NASDAQ:ZYXI Score: +39.26

Electro-therapy, thats their game, but its not what they are about as an investment. They make tons of money for their size.

These folks have increased sales almost in a direct line every month for over two years. What good are increased sales if you don't keep any of the profits? ZYXI operates on a 90% margin as of the last quarter and that is climbing slightly over the past few quarters.

The share price has rocketed over the past year or so based on a continued stream of positive news of order increases, revenues and profits.

In 2007 they earned .07 / share.

Based on some analysis of the 2nd quarter orders increases they should post at a minimum .08 in the first half of 2008. If they simply maintain sales and margins for the remainder of 2008, thats a 229% increase YoY.

As I write this they are trading at 4.74 with about 30 mil shares outstanding for a trailing PE of 43. If I use a non growth estimate of .16 earnings in 2008 thats a PE of under 30.

If they continue to grow at the same pace as they have the past 2 years, estimated earnings for 2008 would be ,22 / share or a PE of 22.

The growth is consistant though they are very small.

Management has a huge stake and has completed every goal they have stated since I have been following them.

They just applied to be listed on the AMEX.

I think I'm going to place my bet in CAPS in the same place my real bucks have been for well over a year and look for something in the mid 7.00 range before the end of 2008 on very conservative assumptions.

Since I own this one personally, keep in mind I am overly enthusiastic about ZYXI, but they have made me a ton in about 18 months and it only makes since to list them in CAPS now that they qualify size wise.

Good Luck.

Leaderboard

Find the members with the highest scoring picks in ZYXI.

Score Leader

krp78

krp78 (99.52) Score: +165.00

The Score Leader is the player with the highest score across all their picks in ZYXI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Borisincincy < 20 8/13/2008 Outperform 1Y $3.33 +204.36% +165.10% +39.26 2 Comments
AllCapSurfer 41.17 8/19/2008 Outperform 1Y $3.39 +198.70% +167.31% +31.39 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hunger4r 87.99 7/18/2019 Outperform 5Y $7.39 +36.94% +10.64% +26.30 0 Comment
stereotyp72 < 20 1/3/2020 Outperform 5Y $8.10 +24.94% +1.81% +23.13 0 Comment
En0chRoot < 20 8/15/2008 9/4/2016 Underperform 5Y $4.14 +144.62% +161.12% +16.50 12 Comments
soth12 62.94 7/26/2019 Outperform 5Y $8.16 +24.02% +9.33% +14.69 0 Comment
drakitin 99.74 8/18/2008 Underperform 3Y $3.92 +158.16% +164.69% +6.53 0 Comment
enricozug 22.69 12/19/2019 Outperform 5Y $9.40 +7.66% +2.82% +4.84 0 Comment
RayNobleEsq 99.98 12/10/2019 Underperform 5Y $10.01 +1.10% +4.78% +3.68 0 Comment
JCSmiley81 73.18 1/23/2020 Underperform 5Y $10.50 -3.62% -0.90% +2.71 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ZYXI.